Skip to content

A multi-institutional observational study of newly-diagnosed pulmonary mucosa-associated lymphoid tissue lymphoma in Japan (PALM-T study)

A multi-institutional observational study of newly-diagnosed pulmonary mucosa-associated lymphoid tissue lymphoma in Japan (PALM-T study) - A multi-institutional observational study of newly-diagnosed pulmonary mucosa-associated lymphoid tissue lymphoma in Japan (PALM-T study)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000052577
Enrollment
150
Registered
2023-10-26
Start date
2023-10-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary mucosa-associated lymphoid tissue lymphoma

Interventions

None listed

Sponsors

Mie University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following criteria are eligible. 1. Patients who were histologically diagnosed with MALT lymphoma between January 1, 2013 and December 31, 2022 2. Patients who have involvement of the lung (lung biopsy is not mandatory)

Exclusion criteria

Exclusion criteria: Patients with one or more of the following are excluded. 1. Patients who were diagnosed as not pulmonary MALT lymphoma based on diagnosis-related information 2. Patients who refused to consent to opt-out

Design outcomes

Primary

MeasureTime frame
Overall survival of patients with newly-diagnosed pulmonary MALT lymphoma diagnosed between 2013 and 2022 at participating institutes

Secondary

MeasureTime frame
Clinical features, treatment choice, toxicity, and risk factors affecting survival in pulmonary MALT lymphoma patients diagnosed between 2013 and 2022 at participating institutes

Countries

Japan

Contacts

Public ContactMotoko Yamaguchi

Mie University Graduate School of Medicine Department of Hematological Malignancies

myamaguchi@clin.medic.mie-u.ac.jp059-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026